Analysis: A new peer-reviewed study published by Cureus (Part of Springer Nature Group) August 8 found a 74 percent reduction in excess deaths in 10 states in Peru with the most intensive ivermectin use over a 30-day period following peak deaths during the COVID-19 pandemic. This is contrary to past public health official assertions for treatment.
When ivermectin was available without restriction, there was a fourteenfold reduction in nationwide excess deaths. Once access to ivermectin was restricted by the government, a thirteenfold increase in excess deaths was observed in the two months following the limitation of its use. The findings align with summary data from the World Health Organization for the same time period in Peru.
Continue reading